Table 6.
Clinical scores following PI3V challenge
| PI3V | Clinical scores in control animals: days post PI3V challenge | ||||||||||||||
| Animal ID | 0–>5 | 6 | 7 | 8 | 9 | 10 | 11 | 12–>14 | Total clinical score | ||||||
| 0 | ND | OD | ND | OD | ND | OD | ND | OD | ND | OD | ND | OD | 0 | ||
| 632181 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 2 | ||
| 643429 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| 643433 | 1 | 0 | 1 | 2 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 10 | ||
| 689106 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 0 | 1 | 1 | 0 | 12 | ||
| 689109 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 5 | ||
| Clinical scores in vaccinated MDA− animals: days post PI3V challenge | |||||||||||||||
| 637676 | 0 | 0 | |||||||||||||
| 643435 | 0 | 0 | |||||||||||||
| 643436 | 0 | 0 | |||||||||||||
| 643437 | 0 | 0 | |||||||||||||
| 643439 | 0 | 0 | |||||||||||||
| 643440 | 0 | 0 | |||||||||||||
| Clinical scores in vaccinated MDA+ animals: days post PI3V challenge | |||||||||||||||
| 643425 | 1 (day 5, ND)* | 0 | 1 | ||||||||||||
| 643426 | 0 | 0 | |||||||||||||
| 643428 | 0 | 0 | |||||||||||||
| 643430 | 0 | 0 | |||||||||||||
| 643431 | 0 | 0 | |||||||||||||
| 689107 | 0 | 0 | |||||||||||||
*Clinical score 1: mild nasal discharge in one vaccinated MDA+ calf (on day 5 post challenge).
MDA, maternally derived antibodies; ND, nasal discharge; OD, ocular discharge; PI3V, parainfluenza type 3 virus.